Navigation Links
Frost & Sullivan's 2009 Excellence in Healthcare Awards Banquet Honours Industry's Top Performers

LONDON, Oct. 12 /PRNewswire/ -- Outstanding performances in Europe's healthcare industry were recognised at Frost & Sullivan's '2009 Excellence in Healthcare Awards Banquet,' held in London on 8th October 2009. 17 leading companies were presented with awards at this prestigious event.


Recipients from a range of healthcare sectors, including drug discovery technologies, healthcare and life sciences IT, medical imaging and honourees were lauded for exceptional product innovation and differentiation, business development strategies and market leadership.

Frost & Sullivan's highly competitive awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

Delivering the keynote address on emerging Healthcare markets, Mr. Sumit Sharma, Senior Vice President (Global), Emerging Markets & New Business Healthcare Practice Director, Frost & Sullivan, said, "As the key Healthcare markets begin to saturate and the overall spending by the governments on Healthcare is challenged, the need for new markets and growth avenues become more important than ever before. One such opportunity is China. The recent reforms in China have resulted in the opening up of the doors for MNCs to penetrate more into this ever expanding and dynamic market. The biggest opportunities in China are being created by the increasing focus of urbanisation by the government that leads to improvements in the Healthcare systems for every strata of the population, sophistication of hospitals, improved IP regulations and the greater need for superior commercialisation plans. All in all, China promises to be the biggest growth opportunity for the Healthcare companies in the west, irrespective of their size."

Following this address was the evening's highlight - the awards presentation recognising outstanding performers in the healthcare arena over the past year:

  • Touch Bionics - 2009 European Bionic Limbs Hot Investment Opportunity Award
  • Ziehm Imaging - 2009 European Mobile C-Arms Business Development Strategy Leadership Award
  • ERGONEX Pharma - 2009 European Orphan Diseases Entrepreneurial Company Award
  • Mennen Medical Ltd - 2009 European Patient Monitoring Technology Leadership of the Year Award
  • TCLAND EXPRESSION - 2009 European Biomarker Discovery and Development Entrepreneurial Company of the Year Award
  • TCLAND EXPRESSION - 2009 European Gene Expression Biomarkers Technology Innovation Award
  • Cegedim Dendrite - 2009 World LifeSciences-IT Market Leadership Award
  • InterSystems - 2009 European Hospital Information System Customer Value Leadership Award
  • Anoto - 2009 European Care Management Systems Industry Innovation & Advancement Award
  • Viatronix Incorporated - 2009 European Medical Imaging Emerging Company of the Year Award
  • Phillips Healthcare - 2009 European Fluoroscopy Product Quality Leadership Award

The Frost & Sullivan Healthcare Awards Banquet honoured Europe's best healthcare companies for their achievements over the course of this year. At a time of global recession and recovery, these award winners have devised strategies to stay on top of their markets and realise competitive excellence.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit

    Jasmine Malone
    Promotions Coordinator, Best Practices
    DDI: +44 (0) 207 915 7869

SOURCE Frost & Sullivan

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award
2. Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan
3. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
4. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
5. Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities
6. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
7. Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
8. Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation
9. Frost & Sullivan: Lower Import Duties and Rising Customer Demand to Boost Russian Electronics Manufacturing Market
10. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
11. The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Imagine Exhibitions and Universal Partnerships ... opening in March 2016 at Melbourne Museum in Melbourne, Australia. Immediately following the ... American tour dates. The Exhibition is based on Universal Pictures’ Jurassic World, one ...
(Date:11/30/2015)... DIEGO , Nov. 30, 2015  HUYA Bioscience ... China,s pharmaceutical innovations, today announced it ... Drug Development Fund (KDDF) to foster collaboration between KDDF ... development and commercialization of healthcare products for the global ... as an important source of new innovative preclinical and ...
(Date:11/30/2015)... -- Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW Bio"), a ... solid tumor cancers, announced today that the Board is ... Company welcomes Neil Woodford,s call for an ... report on NW Bio.  The Company,s Board is under ... stated, "We agree with Mr. Woodford that, at NW ...
(Date:11/27/2015)... CHESTERFIELD, United Kingdom , Nov. 27, 2015 /PRNewswire/--  ... specialty biopharmaceutical company, announced today that it has closed ... systems (CMDS) business to Guerbet (GBT- NYSE Euronext) in ... CMDS operations encompassed four manufacturing facilities and a total ... nearly 75 in the St. Louis ...
Breaking Biology Technology:
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Sensors - Technology and Patent Infringement Risk Analysis" ... --> Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... 17, 2015  Vigilant Solutions announces today that Mr. ... of Directors. --> --> ... from the partnership at TPG Capital, one of the ... $140 Billion in revenue.  He founded and led TPG,s ... TPG companies, from 1997 to 2013.  In his first ...
Breaking Biology News(10 mins):